Treatment-emergent mutations in myelodysplastic syndrome with del(5q) - lenalidomide related or disease-intrinsic clonal evolution?

被引:1
作者
Abdallah, Mostafa [1 ]
Reichard, Kaaren [1 ]
Gangat, Naseema [1 ]
Tefferi, Ayalew [1 ]
机构
[1] Mayo Clin, Rochester, MN 55905 USA
关键词
TP53; MUTATIONS; PREVALENCE;
D O I
10.1038/s41408-024-01027-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:4
相关论文
共 15 条
[1]   International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data [J].
Arber, Daniel A. ;
Orazi, Attilio ;
Hasserjian, Robert P. ;
Borowitz, Michael J. ;
Calvo, Katherine R. ;
Kvasnicka, Hans-Michael ;
Wang, Sa A. ;
Bagg, Adam ;
Barbui, Tiziano ;
Branford, Susan ;
Bueso-Ramos, Carlos E. ;
Cortes, Jorge E. ;
Dal Cin, Paola ;
DiNardo, Courtney D. ;
Dombret, Herve ;
Duncavage, Eric J. ;
Ebert, Benjamin L. ;
Estey, Elihu H. ;
Facchetti, Fabio ;
Foucar, Kathryn ;
Gangat, Naseema ;
Gianelli, Umberto ;
Godley, Lucy A. ;
Gokbuget, Nicola ;
Gotlib, Jason ;
Hellstrom-Lindberg, Eva ;
Hobbs, Gabriela S. ;
Hoffman, Ronald ;
Jabbour, Elias J. ;
Kiladjian, Jean-Jacques ;
Larson, Richard A. ;
Le Beau, Michelle M. ;
Loh, Mignon L. -C. ;
Lowenberg, Bob ;
Macintyre, Elizabeth ;
Malcovati, Luca ;
Mullighan, Charles G. ;
Niemeyer, Charlotte ;
Odenike, Olatoyosi M. ;
Ogawa, Seishi ;
Orfao, Alberto ;
Papaemmanuil, Elli ;
Passamonti, Francesco ;
Porkka, Kimmo ;
Pui, Ching-Hon ;
Radich, Jerald P. ;
Reiter, Andreas ;
Rozman, Maria ;
Rudelius, Martina ;
Savona, Michael R. .
BLOOD, 2022, 140 (11) :1200-1228
[2]   TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases [J].
Fleti, Farah ;
Chan, Onyee ;
Singh, Amritpal ;
Abdelmagid, Maymona G. ;
Al-Kali, Aref ;
Elliott, Michelle A. ;
Begna, Kebede H. ;
Foran, James M. ;
Badar, Talha ;
Khera, Nandita ;
Al Ali, Najla H. ;
Padron, Eric ;
Sallman, David A. ;
Shah, Mithun ;
Hiwase, Devendra ;
Pardanani, Animesh ;
Arber, Daniel A. ;
Orazi, Attilio ;
Reichard, Kaaren K. ;
He, Rong ;
Ketterling, Rhett P. ;
Gangat, Naseema ;
Komrokji, Rami ;
Tefferi, Ayalew .
AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (04) :E76-E79
[3]   Emergence of TP53 mutation during lenalidomide therapy of myelodysplastic syndrome with del(5q) and its subsequent disappearance following salvage therapy with decitabine [J].
Gangat, Naseema ;
Bellam, Naresh ;
Reichard, Kaaren ;
Tefferi, Ayalew .
HAEMATOLOGICA, 2024, 109 (04) :1306-1309
[4]   Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q Deletion [J].
Garderet, Laurent ;
Ziagkos, Dimitris ;
Van Biezen, Anja ;
Lacobelli, Simona ;
Finke, Juergen ;
Maertens, Johan ;
Volin, Liisa ;
Ljungman, Per ;
Chevallier, Patrice ;
Passweg, Jakob ;
Schaap, Nicolaas ;
Beelen, Dietrich ;
Nagler, Arnon ;
Blaise, Didier ;
Poire, Xavier ;
Yakoub-Agha, Ibrahim ;
Lenhoff, Stig ;
Craddock, Charles ;
Schots, Rik ;
Rambaldi, Alessandro ;
Sanz, Jaime ;
Jindra, Pavel ;
Mufti, Ghulam J. ;
Robin, Marie ;
Kroeger, Nicolaus .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) :507-513
[5]   Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide [J].
Gurnari, Carmelo ;
Piciocchi, Alfonso ;
Soddu, Stefano ;
Bonanni, Fabrizio ;
Scalzulli, Emilia ;
Niscola, Pasquale ;
Di Veroli, Ambra ;
Piccioni, Anna Lina ;
Piedimonte, Monica ;
Maiorana, Gianluca ;
Salutari, Prassede ;
Cicconi, Laura ;
Santopietro, Michelina ;
Gumenyuk, Svitlana ;
Sarlo, Chiara ;
Fenu, Susanna ;
Tafuri, Agostino ;
Latagliata, Roberto ;
Fianchi, Luana ;
Criscuolo, Marianna ;
Maciejewski, Jaroslaw P. ;
Maurillo, Luca ;
Buccisano, Francesco ;
Breccia, Massimo ;
Voso, Maria Teresa .
BLOOD CANCER JOURNAL, 2022, 12 (09)
[6]   Clonal heterogeneity in the 5q-syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression [J].
Jadersten, Martin ;
Saft, Leonie ;
Pellagatti, Andrea ;
Goehring, Gudrun ;
Wainscoat, James S. ;
Boultwood, Jacqueline ;
Porwit, Anna ;
Schlegelberger, Brigitte ;
Hellstrom-Lindberg, Eva .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (12) :1762-1766
[7]   TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression [J].
Jaedersten, Martin ;
Saft, Leonie ;
Smith, Alexander ;
Kulasekararaj, Austin ;
Pomplun, Sabine ;
Goehring, Gudrun ;
Hedlund, Anette ;
Hast, Robert ;
Schlegelberger, Brigitte ;
Porwit, Anna ;
Hellstrom-Lindberg, Eva ;
Mufti, Ghulam J. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) :1971-1979
[8]   Efficacy of lenalidomide in myelodysplastic syndromes [J].
List, A ;
Kurtin, S ;
Roe, DJ ;
Buresh, A ;
Mahadevan, D ;
Fuchs, D ;
Rimsza, L ;
Heaton, R ;
Knight, R ;
Zeldis, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (06) :549-557
[9]   Emergence and evolution of TP53 mutations are key features of disease progression in myelodysplastic patients with lower-risk del(5q) treated with lenalidomide [J].
Lode, Laurence ;
Menard, Audrey ;
Flet, Laurent ;
Richebourg, Steven ;
Loirat, Marion ;
Eveillard, Marion ;
Le Bris, Yannick ;
Godon, Catherine ;
Theisen, Olivier ;
Gagez, Anne-Laure ;
Cartron, Guillaume ;
Commes-Maerten, Therese ;
Villemagne, Bruno ;
Luycx, Odile ;
Godmer, Pascal ;
Pellat-Deceunynck, Catherine ;
Soussi, Thierry ;
Bene, Marie C. ;
Delaunay, Jacques ;
Peterlin, Pierre .
HAEMATOLOGICA, 2018, 103 (04) :E143-E146
[10]   Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS) [J].
Mossner, M. ;
Jann, J-C ;
Nowak, D. ;
Platzbecker, U. ;
Giagounidis, A. ;
Goetze, K. ;
Letsch, A. ;
Haase, D. ;
Shirneshan, K. ;
Braulke, F. ;
Schlenk, R. F. ;
Haferlach, T. ;
Schafhausen, P. ;
Bug, G. ;
Luebbert, M. ;
Ganser, A. ;
Buesche, G. ;
Schuler, E. ;
Nowak, V. ;
Pressler, J. ;
Oblaender, J. ;
Fey, S. ;
Mueller, N. ;
Lauinger-Loersch, E. ;
Metzgeroth, G. ;
Weiss, C. ;
Hofmann, W-K ;
Germing, U. ;
Nolte, F. .
LEUKEMIA, 2016, 30 (09) :1956-1959